Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,617 across all filing types
Latest filing 2018-05-18 Regulatory Filings
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
更正公告本公司子公司白木屋食品(股)公司 因停業而停工
Regulatory Filings Classification · 95% confidence The document is a short announcement from a listed company (3164 景岳) regarding the cessation of operations of its subsidiary 白木屋食品(股)公司 due to continuous losses. It includes details about the decision, financial impact, and employee arrangements. The document is brief (1170 characters) and does not contain comprehensive financial statements or detailed financial analysis. It is an operational update related to a subsidiary's business status rather than a full financial report or earnings release. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about a significant operational event but does not meet criteria for other specific categories like Earnings Release or Management Reports.
2018-05-18 Chinese
本公司取得子公司白木屋食品(股)公司房屋兩棟
Capital/Financing Update Classification · 95% confidence The document is a disclosure from a listed company (3164 景岳) about acquiring two buildings through its subsidiary. It details the transaction specifics such as property locations, prices, transaction dates, related parties, valuation reports, and board approval dates. The content focuses on a related-party transaction involving asset acquisition, including compliance with regulations on asset acquisition or disposal by public companies. There is no indication that this is a full financial report, earnings release, or management discussion. The document is a regulatory announcement about a specific capital asset transaction, fitting the category of Capital/Financing Update (CAP). The document length is short (1940 characters), but it contains detailed transaction information rather than just announcing a report publication or certification. Therefore, it is classified as CAP with high confidence.
2018-05-18 Chinese
本公司投資子公司景岳生物科技(中國)有限公司
Capital/Financing Update Classification · 95% confidence The document is a regulatory announcement from a listed company (3164 景岳) disclosing details about an investment transaction involving its subsidiary 景岳生物科技(中國)有限公司. It includes specific financial figures related to the investment amount, dates, board approval, and related party transaction details. The document is short (2034 characters) and structured as a formal disclosure rather than a full financial report. It does not contain comprehensive financial statements or detailed analysis typical of annual or interim reports. It also does not fit categories like earnings release, management report, or audit report. The content aligns with a Capital/Financing Update (CAP) as it reports on a capital investment transaction and related approvals. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2018-05-18 Chinese
公告本公司子公司白木屋食品(股)公司因停業而停工
Regulatory Filings Classification · 95% confidence The document is a short announcement (717 characters) from a listed company about its subsidiary ceasing operations due to continuous losses. It includes specific event details such as the date, decision process, and impact on revenue. There is no financial data, no report attached or referenced, and no indication of a full financial report or management discussion. The content fits the category of a regulatory announcement about a significant operational event rather than a financial report or management report. Therefore, it best fits under Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2018-05-18 Chinese
代本公司子公司白木屋食品(股)公司公告 因停業而停工
Regulatory Filings Classification · 95% confidence The document is a short announcement (719 characters) from a listed company (3164 景岳) reporting that its subsidiary has ceased operations due to continuous losses. It includes specific event details such as the date, decision process, and impact on revenue. There is no financial data, no mention of a report being attached or published, and no detailed financial statements or analysis. The content is a regulatory disclosure about a significant operational event, fitting the category of a general regulatory announcement rather than a financial report or management discussion. Therefore, it best fits the Regulatory Filings (RNS) category as a general compliance disclosure.
2018-05-18 Chinese
107年第1季大陸投資
Regulatory Filings Classification · 95% confidence The document is a tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes details such as capital amounts, investment methods, cumulative investment amounts, and recognized investment gains or losses for a specific quarter (Year 107, Quarter 1 in the Taiwanese calendar). The document is short (1304 characters) and primarily provides regulatory disclosure data about overseas investments, consistent with regulatory filing requirements in Taiwan. There is no indication that this is a full financial report, audit report, or earnings release. It is not a meeting material, nor a voting result, nor a management or board announcement. The document is a regulatory disclosure of investment information, which fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2018-05-15 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.